C. Gregory Peters
Stock Analyst at Raymond James
(4.66)
# 182
Out of 4,893 analysts
205
Total ratings
71.05%
Success rate
14.11%
Average return
Main Sectors:
Stocks Rated by C. Gregory Peters
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Reiterates: Strong Buy | $115 → $120 | $97.19 | +23.47% | 13 | Jul 8, 2025 | |
| HMN Horace Mann Educators | Maintains: Strong Buy | $46 → $49 | $40.55 | +20.85% | 2 | May 15, 2025 | |
| EG Everest Group | Reiterates: Strong Buy | $420 → $410 | $340.45 | +20.43% | 2 | May 6, 2025 | |
| ALL The Allstate Corporation | Reiterates: Strong Buy | $240 → $250 | $194.68 | +28.42% | 24 | May 5, 2025 | |
| HIG The Hartford Insurance Group | Maintains: Outperform | $125 → $135 | $121.76 | +10.87% | 7 | Mar 31, 2025 | |
| MCY Mercury General | Upgrades: Strong Buy | $70 → $80 | $66.24 | +20.77% | 6 | Feb 12, 2025 | |
| MMC Marsh & McLennan Companies | Reiterates: Outperform | $240 → $250 | $214.71 | +16.44% | 17 | Feb 6, 2025 | |
| KMPR Kemper | Maintains: Strong Buy | $75 → $82 | $61.59 | +33.14% | 13 | Dec 26, 2024 | |
| HGTY Hagerty | Downgrades: Underperform | n/a | $10.08 | - | 2 | Dec 26, 2024 | |
| PGR The Progressive Corporation | Upgrades: Outperform | $305 | $249.38 | +22.30% | 20 | Dec 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Strong Buy | $365 → $400 | $309.69 | +29.16% | 10 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $10.85 | +47.47% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $45 → $55 | $53.35 | +3.09% | 8 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $110 | $107.74 | +2.10% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $40 → $45 | $41.24 | +9.12% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $270 → $285 | $280.54 | +1.59% | 8 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $220 → $245 | $256.17 | -4.36% | 7 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $313.80 | - | 18 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $255 → $260 | $302.82 | -14.14% | 8 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $29 → $30 | $36.63 | -18.10% | 8 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $358.85 | - | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $147.79 | - | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $70.72 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $67 | $102.21 | -34.45% | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.15 | - | 4 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.13 | - | 4 | Feb 1, 2021 |
HealthEquity
Jul 8, 2025
Reiterates: Strong Buy
Price Target: $115 → $120
Current: $97.19
Upside: +23.47%
Horace Mann Educators
May 15, 2025
Maintains: Strong Buy
Price Target: $46 → $49
Current: $40.55
Upside: +20.85%
Everest Group
May 6, 2025
Reiterates: Strong Buy
Price Target: $420 → $410
Current: $340.45
Upside: +20.43%
The Allstate Corporation
May 5, 2025
Reiterates: Strong Buy
Price Target: $240 → $250
Current: $194.68
Upside: +28.42%
The Hartford Insurance Group
Mar 31, 2025
Maintains: Outperform
Price Target: $125 → $135
Current: $121.76
Upside: +10.87%
Mercury General
Feb 12, 2025
Upgrades: Strong Buy
Price Target: $70 → $80
Current: $66.24
Upside: +20.77%
Marsh & McLennan Companies
Feb 6, 2025
Reiterates: Outperform
Price Target: $240 → $250
Current: $214.71
Upside: +16.44%
Kemper
Dec 26, 2024
Maintains: Strong Buy
Price Target: $75 → $82
Current: $61.59
Upside: +33.14%
Hagerty
Dec 26, 2024
Downgrades: Underperform
Price Target: n/a
Current: $10.08
Upside: -
The Progressive Corporation
Dec 26, 2024
Upgrades: Outperform
Price Target: $305
Current: $249.38
Upside: +22.30%
Dec 5, 2024
Upgrades: Strong Buy
Price Target: $365 → $400
Current: $309.69
Upside: +29.16%
Nov 12, 2024
Maintains: Outperform
Price Target: $15 → $16
Current: $10.85
Upside: +47.47%
Nov 5, 2024
Maintains: Strong Buy
Price Target: $45 → $55
Current: $53.35
Upside: +3.09%
Jul 25, 2024
Maintains: Outperform
Price Target: $95 → $110
Current: $107.74
Upside: +2.10%
May 22, 2024
Reiterates: Strong Buy
Price Target: $40 → $45
Current: $41.24
Upside: +9.12%
Feb 1, 2024
Maintains: Strong Buy
Price Target: $270 → $285
Current: $280.54
Upside: +1.59%
Jan 22, 2024
Maintains: Strong Buy
Price Target: $220 → $245
Current: $256.17
Upside: -4.36%
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $313.80
Upside: -
Nov 2, 2023
Maintains: Outperform
Price Target: $255 → $260
Current: $302.82
Upside: -14.14%
Oct 30, 2023
Maintains: Outperform
Price Target: $29 → $30
Current: $36.63
Upside: -18.10%
Oct 31, 2022
Downgrades: Underperform
Price Target: n/a
Current: $358.85
Upside: -
Sep 23, 2022
Initiates: Market Perform
Price Target: n/a
Current: $147.79
Upside: -
Jun 7, 2022
Initiates: Market Perform
Price Target: n/a
Current: $70.72
Upside: -
Feb 7, 2022
Maintains: Outperform
Price Target: $60 → $67
Current: $102.21
Upside: -34.45%
Aug 12, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $6.15
Upside: -
Feb 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.13
Upside: -